Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scott

Showing results (151-160 of 355) with videos related to

Pageof 36
Sort By:
Diabetes|July 18, 2008
Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistanceWinifred P S Wong, David W Scott, Chia-Lin Chuang, et al.
Cancers|February 25, 2022
Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60Dean A Regier, Brandon Chan, Sarah Costa, et al.
Hemasphere|April 4, 2022
Concurrent Composite Lymphomas Collectively Bearing Three Diagnostic Entities of Shared Clonal OriginWaleed Alduaij, Laura K Hilton, Muntadhar Al Moosawi, et al.
Scientific Reports|July 30, 2020
Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCRMiguel Alcaide, Matthew Cheung, Jack Hillman, et al.
British Journal of Haematology|August 12, 2022
Clinicopathological characteristics and long-term outcomes of plasmablastic lymphoma in British ColumbiaRehan Jessa, Nicole Chien, Diego Villa, et al.
American Journal of Respiratory and Critical Care Medicine|May 9, 2017
SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus TransportDavid W Scott, Matthew P Walker, Juliana Sesma, et al.
Haematologica|June 22, 2019
Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphomaGrzegorz S Nowakowski, Annalisa Chiappella, Thomas E Witzig, et al.
Journal of Clinical Pathology|January 5, 2024
Multisite clinical cross-validation and variant interpretation of a next generation sequencing panel for lymphoid cancer prognosticationPeter J B Sabatini, Josh Bridgers, Shujun Huang, et al.
Blood|September 19, 2019
The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISHLaura K Hilton, Jeffrey Tang, Susana Ben-Neriah, et al.
The Journal of Molecular Diagnostics : JMD|October 12, 2025
Validation of a Modular Gene Expression Assay for Risk Stratification and Subtyping LymphomasPeter J B Sabatini, Josh Bridgers, Shujun Huang, et al.
Pageof 36

Showing results (151-160 of 355) with videos related to

Sort By:
Pageof 36
Diabetes|July 18, 2008
Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistanceWinifred P S Wong, David W Scott, Chia-Lin Chuang, et al.
Cancers|February 25, 2022
Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60Dean A Regier, Brandon Chan, Sarah Costa, et al.
Hemasphere|April 4, 2022
Concurrent Composite Lymphomas Collectively Bearing Three Diagnostic Entities of Shared Clonal OriginWaleed Alduaij, Laura K Hilton, Muntadhar Al Moosawi, et al.
Scientific Reports|July 30, 2020
Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCRMiguel Alcaide, Matthew Cheung, Jack Hillman, et al.
British Journal of Haematology|August 12, 2022
Clinicopathological characteristics and long-term outcomes of plasmablastic lymphoma in British ColumbiaRehan Jessa, Nicole Chien, Diego Villa, et al.
American Journal of Respiratory and Critical Care Medicine|May 9, 2017
SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus TransportDavid W Scott, Matthew P Walker, Juliana Sesma, et al.
Haematologica|June 22, 2019
Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphomaGrzegorz S Nowakowski, Annalisa Chiappella, Thomas E Witzig, et al.
Journal of Clinical Pathology|January 5, 2024
Multisite clinical cross-validation and variant interpretation of a next generation sequencing panel for lymphoid cancer prognosticationPeter J B Sabatini, Josh Bridgers, Shujun Huang, et al.
Blood|September 19, 2019
The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISHLaura K Hilton, Jeffrey Tang, Susana Ben-Neriah, et al.
The Journal of Molecular Diagnostics : JMD|October 12, 2025
Validation of a Modular Gene Expression Assay for Risk Stratification and Subtyping LymphomasPeter J B Sabatini, Josh Bridgers, Shujun Huang, et al.
Pageof 36